期刊文献+

Galectin-3蛋白在结直肠癌中的表达及临床意义

Expression of Galectin-3 protein in colorectal cancer and their clinical effects
下载PDF
导出
摘要 目的研究Galectin-3蛋白在结直肠癌中的表达及其与临床病理特征的关系。方法采用快捷免疫组化MaxVi-sionTM法对50例正常结肠黏膜组织、60例结肠腺瘤性息肉组织、152例结直肠癌中Galectin-3蛋白进行检测。结果 Galec-tin-3蛋白在结直肠癌中的阳性率与正常结肠黏膜组织、结肠腺瘤性息肉组织相比,其差异均有统计学意义(P<0.05)。在结直肠癌中,Galectin-3蛋白的表达与肿瘤的临床分期、组织的分化程度及有无淋巴结转移有关,临床分期越晚、组织分化越差,Galectin-3蛋白表达越高,有淋巴结转移组的表达率高于无淋巴结转移组,其差异均有统计学意义(P<0.05)。结论 Galec-tin-3蛋白在结直肠癌的发生发展中起着重要作用。 Objective To investigate the expression of Galectin-3 protein in colorectal cancer and to find out their relationships with clinical pathological features.Methods Expression of Galectin-3 protein was detected in 50 cases of normal mucosa tissues,60 cases of adenoma tissues and 152 cases of colorectal cancer tissues with immunohistochemical MaxVisionTM technique.Results There was significant difference(P〈0.05) for the positive rates of Galectin-3 protein in colorectal cancer in tissues,normal mucosa tissues and adenoma tissues.In colorectal cancer tissues,expression of Galectin-3 Protein was closely related to clinical stage,differentiated degree and lymph node metastasis.With clinical stage later and differentiated degree worse,expression of Galectin-3 Protein became more higher.Expression of Galectin-3 protein was higher in lymph node metastasis than that without lymph node metastasis,there was significant difference(P〈0.05).Conclusion Galectin-3 protein plays an important role in the oncogenesis and development of colorectal cancer.
出处 《结直肠肛门外科》 2011年第6期363-365,共3页 Journal of Colorectal & Anal Surgery
关键词 结直肠肿瘤 GALECTIN-3蛋白 免疫组织化学 Colorectal tomur Galectin-3 Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献27

  • 1WILENTZ R E, LACOBUZIO- DONAHUE C A,ARGANI R, et aL Loss of expression of Dpc4 in pancreatic intraepithelial neo-plasia:evidence that DPC4 inactivation occurs late in neoplastic progression[J]. Cancer Res, 2000, 60(7): 52002- 2006.
  • 2O' BRIEN C. Newtumor suppressor found in pancreatic cancer[J]. Science, 1996, 271(5247): 294.
  • 3FUKUMORI T, TAKENAKA Y, YOSHII T, et al. CD29 and CD7 mediate galectin-3 -induced type II T-cell apoptosis [J]. Cancer Res, 2003, 63(23): 8302-11.
  • 4YOSHII I, INOHARA H, TAKENKA Y, et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells[J]. Int J Oneol, 2001, 18: 787-792.
  • 5MASSAGUIEJ, SEOANE J, WOTTON D. Smad transcription factors[J]. Genes Dev, 2005, 19: 2783-2810.
  • 6MIYAKI M, IIJIMA T, KONISHI M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis[J]. Oncogene, 1999, 18: 3098-3103.
  • 7WILENTZ RE, SU GH, DAI JL, et al. Immuno-histochemical labeling for Dpc4 mirrors genetic status in pancreatic adeno-carcinomas[J]. Am J Pathol, 2000, 156: 37-43.
  • 8DE BOSSCHER K, HILL CS, NICOLAS FJ. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells [J]. Biochem J, 2004, 379 (Ptl): 209-216.
  • 9RONDES SH, COOPER DNW, GITI" MA, et al. Galectins, structure and function of a large family of animal lectins [J]. J Biol Chem, 1994, 269: 20807-20819.
  • 10AKAHANI S, NANGIA-MAKKER P, INOHARA H, et al.Galectin-3, a novel anti- apoptotic molecule with a functional BHI (NWGR) domain of Bel-2 family [J].Cancer Res, 1997, 57: 5272-5276.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部